WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML

Mark Identification

Proof of use for DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML

We do not have any records of a proof of use for DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML at this moment.

Click here to add a proof of use for DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML

Possible trademark infringements of DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML

Basic Information

Serial Number
86658328
Filing Date
10 Jun 2015
Registration Number
5271686
Registration Date
22 Aug 2017
Mark Drawing Code
3

Classifications

Declare the trademark use of DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML on the blockchain with WikiTrademarks.io.

First use anywhere
DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML was first used on 18 May 2017 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
2
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Ownership history of this trademark/brand

1. Hospira, Inc. Lake Forest IL

2. Hospira, Inc. Lake Forest IL

3. Hospira, Inc. Lake Forest IL

Correspondent

Richard A. Friedman
235 East 42nd Street
New York, NY 10017-5703

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on DYLOJECT (DICLOFENAC SODIUM) INJECTION 37.5 MG/ML